AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020High seroprevalence of viral hepatitis among animal handlers in Abeokuta, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Seroprevalence of hepatitis B surface antigen (HBsAG) and hepatitis C antibodies (HCVAb) among hemodialysis patients at the Yaounde General Hospital, Cameroon.View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Seroprevalence of viral hepatitis among health care workers (HCWS) in Taraba state, NigeriaView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Viral hepatitis B and C seroprevalence among at risk population in Taraba state: a seroprevalence studyView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Comparative analysis of hepatitis B virus serologic profiles and biochemical markers with viral loads in Ondo, Nigeria.View Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Short Chain Fatty Acids Delay the Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma in an HBx transgenic mouse modelView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Global elimination of hepatitis C: meeting the World Health Organization’s 2030 goalView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Gilead Sciences’ Commitment to Global Elimination of Hepatitis C VirusView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Contact tracing to engage hard to reach injection networks and achieve micro-elimination: description of the ‘source patient indentification and group overlap treatment’ (spigot) pilot programView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Ledipasvir 90 mg/ Sofosbuvir 400 mg for treatment of Chronic Hepatitis C genotype 4 adolescents: Towards elimination of hepatitis in childrenView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Hep Free 2030: Planning for Hepatitis Elimination in Hawai`i as Nimble, Collaborative PracticeView Abstract
AbstractViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2020Results of A Hepatitis C (HCV) Re-Engagement Strategy For Vulnerable PopulationsView Abstract
